中国医药
中國醫藥
중국의약
CHINA MEDICINE
2009年
4期
253-254
,共2页
王志晔%张作念%顾伟%潘振华%朱诚%潘锡近
王誌曄%張作唸%顧偉%潘振華%硃誠%潘錫近
왕지엽%장작념%고위%반진화%주성%반석근
缺血性脑卒中%氯吡格雷%溶血磷脂酸
缺血性腦卒中%氯吡格雷%溶血燐脂痠
결혈성뇌졸중%록필격뢰%용혈린지산
Cerebral infarction%Clopidogrel%Lysophosphatidic
目的 探讨氯吡格雷对急性脑梗死患者血浆溶血磷脂酸(LPA)水平及血小板功能的影响.方法 选择明确诊断的急性脑梗死患者62例,完全随机分为2组:氯吡格雷组30例,除常规治疗外口服氯吡格雷75 mg/d;对照组32例,根据病情适当给予脱水、胞二磷胆碱营养脑细胞等常规治疗.分别测定2组患者治疗前及治疗2周后LPA水平,同时进行神经功能缺损评分.结果 2组血浆LPA水平及神经功能缺损评分较同组治疗前均明显下降,差异有统计学意义(P<0.01);氯吡格雷组治疗后血浆LPA水平及神经功能缺损评分均较对照组治疗后明显下降,差异有统计学意义(P<0.01).结论 氯吡格雷能有效降低血浆LPA水平,降低神经功能缺损评分.
目的 探討氯吡格雷對急性腦梗死患者血漿溶血燐脂痠(LPA)水平及血小闆功能的影響.方法 選擇明確診斷的急性腦梗死患者62例,完全隨機分為2組:氯吡格雷組30例,除常規治療外口服氯吡格雷75 mg/d;對照組32例,根據病情適噹給予脫水、胞二燐膽堿營養腦細胞等常規治療.分彆測定2組患者治療前及治療2週後LPA水平,同時進行神經功能缺損評分.結果 2組血漿LPA水平及神經功能缺損評分較同組治療前均明顯下降,差異有統計學意義(P<0.01);氯吡格雷組治療後血漿LPA水平及神經功能缺損評分均較對照組治療後明顯下降,差異有統計學意義(P<0.01).結論 氯吡格雷能有效降低血漿LPA水平,降低神經功能缺損評分.
목적 탐토록필격뢰대급성뇌경사환자혈장용혈린지산(LPA)수평급혈소판공능적영향.방법 선택명학진단적급성뇌경사환자62례,완전수궤분위2조:록필격뢰조30례,제상규치료외구복록필격뢰75 mg/d;대조조32례,근거병정괄당급여탈수、포이린담감영양뇌세포등상규치료.분별측정2조환자치료전급치료2주후LPA수평,동시진행신경공능결손평분.결과 2조혈장LPA수평급신경공능결손평분교동조치료전균명현하강,차이유통계학의의(P<0.01);록필격뢰조치료후혈장LPA수평급신경공능결손평분균교대조조치료후명현하강,차이유통계학의의(P<0.01).결론 록필격뢰능유효강저혈장LPA수평,강저신경공능결손평분.
Objective To observe the influence of Clopidogre on lysophosphatidic acid (LPA) in acute cerebral infarction. Methods Sixty-two cases of acute cerebral infarction were enrolled, including 30 cases of ther-apeutic group, 32 cases in control group. In the therapeutic group the patients had dehydration, neurotrophic agents and clopidogrel 75 mg/d. The concentration of LPA was measured and the degree of neurofunction defect was ana-lyzed before and 2 weeks after treament. Results The level of LPA and degree of neurofuntion defect decreased af-ter treatment in both groups (P>0.01 ) . There was significant difference in therapeutic group compared with con-trols(P<0.01 ). Conclusion Clopidogre decreases lysophosphatidic in acute cerebral infarction.